活检中Gleason 1级前列腺癌体积与根治性前列腺切除术后升级相关,但与不良病理或复发无关:来自大型机构队列的结果
该研究纳入1029例活检Gleason分级组1、cT1-2N0/xM0/x且PSA<10 ng/mL并接受根治性前列腺切除术的男性,分析阳性针数百分比与病理升级、不良病理及复发的关系。多变量分析显示阳性针数百分比与病理升级显著相关(OR 1.31,95%CI 1.1-1.57,P<.01),但与加州大学旧金山分校不良病理无关(P=.84),与替代不良病理呈负相关(OR 0.67,95%CI 0.48-0.93,P=.02),与复发风险无关(P=.11)。结论认为肿瘤体积可能与病理升级相关,但与不良病理或复发等更具临床意义的结局无关。
要点
- 阳性针数百分比与病理升级显著相关(OR 1.31,95%CI 1.1-1.57,P<.01)。
- 阳性针数百分比与加州大学旧金山分校不良病理无关(P=.84)。
- 阳性针数百分比与替代不良病理呈负相关(OR 0.67,95%CI 0.48-0.93,P=.02)。
核心结论
- 在Gleason分级组1前列腺癌男性中,肿瘤体积可能与根治性前列腺切除术后的病理升级相关,但与不良病理或复发等更具临床意义的结局无关。
研究设计与样本
- 纳入cT1-2N0/xM0/x、诊断时前列腺特异性抗原<10 ng/mL、诊断性活检Gleason分级组1病理并接受初次根治性前列腺切除术的男性,共1029例。
主要发现
- 多变量逻辑回归显示阳性针数百分比与病理升级显著相关(OR 1.31,95%CI 1.1-1.57,P<.01)。
- 阳性针数百分比与加州大学旧金山分校不良病理无关(P=.84)。
- 阳性针数百分比与替代不良病理呈负相关(OR 0.67,95%CI 0.48-0.93,P=.02)。
- 多变量Cox回归显示阳性针数百分比与根治性前列腺切除术后复发风险无关(P=.11)。
关键数值与推荐
- 病理升级定义为根治性前列腺切除术后≥Gleason分级组2。
- 加州大学旧金山分校不良病理定义为≥Gleason分级组3、pT3/4或pN1。
- 替代不良病理定义为≥Gleason分级组3、≥pT3b或pN1。
- 复发定义为生化失败(2次前列腺特异性抗原≥0.2 ng/mL)或挽救治疗。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Clinical guidelines suggest that for low-grade, clinically localized prostate cancer, patients with higher volume of disease at diagnosis may benefit from definitive therapy, although the data remain unclear. Our objective was to determine associations between low-grade prostate cancer volume and outcomes in men managed with primary radical prostatectomy. MATERIALS AND METHODS: Men with cT1-2N0/xM0/x prostate cancer, prostate specific antigen at diagnosis <10 ng/mL, and Gleason grade group 1 pathology on diagnostic biopsy managed with primary radical prostatectomy were included. Outcomes were pathological upgrade at radical prostatectomy (≥Gleason grade group 2), University of California, San Francisco adverse pathology at radical prostatectomy (≥Gleason grade group 3, pT3/4, or pN1), alternate adverse pathology at radical prostatectomy (≥Gleason grade group 3, ≥pT3b, or pN1), and recurrence (biochemical failure with 2 prostate specific antigen ≥0.2 ng/mL or salvage treatment). Multivariable logistic regression models were used to estimate associations between percentage of positive cores and risk of upgrade and adverse pathology at radical prostatectomy. Multivariable Cox proportional hazards regression models were used to estimate associations between percentage of positive cores and hazard of recurrence after radical prostatectomy. RESULTS: A total of 1,029 men met inclusion criteria. Multivariable logistic regression models demonstrated significant associations between percentage of positive cores and pathological upgrade (OR 1.31, 95% CI 1.1-1.57, P < .01), but not University of California, San Francisco adverse pathology at radical prostatectomy (P = .84); percentage of positive cores was negatively associated with alternate adverse pathology (OR 0.67, 95% CI 0.48-0.93, P = .02). Multivariable Cox regression models demonstrated no association between percentage of positive cores and hazard of recurrence after radical prostatectomy (P = .11). CONCLUSIONS: In men with Gleason grade group 1 prostate cancer, tumor volume may be associated with upgrading at radical prostatectomy, but not more clinically significant outcomes of adverse pathology or recurrence.
引用
- Shee K, Washington SL, Cowan JE, et al. Gleason Grade 1 Prostate Cancer Volume at Biopsy Is Associated With Upgrading but Not Adverse Pathology or Recurrence After Radical Prostatectomy: Results From a Large Institutional Cohort. J Urol. 2022. PMID: 36067374. doi:10.1097/JU.0000000000002956
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。